Clinigen Group (CLIN)

Sector:

Food Pharmacy Retail

Index:

FTSE AIM 50

899.00p
   
  • Change Today:
    -16.00p
  • 52 Week High: 1,045.00
  • 52 Week Low: 357.80
  • Currency: UK Pounds
  • Shares Issued: 132.85m
  • Volume: 102,023
  • Market Cap: £1,194.31m

Thursday broker round-up

By Caoimhe Toman

Date: Thursday 19 Sep 2019

LONDON (ShareCast) - (Sharecast News) - Ferguson: RBC Capital Markets downgrades to underperform with a target price of 5,100p.

Kingfisher: UBS reiterates sell with a target price of 180p.

British Land: Barclays reiterates hold with a target price of 600p.

Beazley: Peel Hunt reiterates reduce with a target price of 460p.

Clinigen Group: Peel Hunt reiterates buy with a target price of 1,390p.

Petropavlovsk: Canaccord upgrades to buy with a target price of 16p.

Quixant: Berenberg downgrades to hold with a target price of 175p.

Xeros Technology: Berenberg reiterates buy with a target price of 20p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Clinigen Group Market Data

Currency UK Pounds
Share Price 899.00p
Change Today -16.00p
% Change -1.75 %
52 Week High 1,045.00
52 Week Low 357.80
Volume 102,023
Shares Issued 132.85m
Market Cap £1,194.31m

Clinigen Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
72.43% below the market average72.43% below the market average72.43% below the market average72.43% below the market average72.43% below the market average
84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average
Price Trend
49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average
38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average
Income
87.02% below the market average87.02% below the market average87.02% below the market average87.02% below the market average87.02% below the market average
81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average
Growth
58.76% above the market average58.76% above the market average58.76% above the market average58.76% above the market average58.76% above the market average
84.62% above the sector average84.62% above the sector average84.62% above the sector average84.62% above the sector average84.62% above the sector average

What The Brokers Say

Strong Buy 7
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Clinigen Group Dividends

  Latest Previous
  Interim Final
Ex-Div 19-Mar-20 07-Nov-19
Paid 17-Apr-20 29-Nov-19
Amount 2.15p 4.75p

Trades for 04-Jun-2020

Time Volume / Share Price
10:53 84 @ 899.00p
10:53 88 @ 899.00p
10:53 90 @ 899.50p
10:53 265 @ 900.50p
10:53 35 @ 900.50p

Clinigen Group Key Personnel

CEO Shaun Edward Chilton

Top of Page